Headline
The latest stories from AHA Today.
Judy Rich, R.N., former AHA Board member and Tucson Medical Center CEO, leads a discussion on how to build formal board development plans that help trustees better understand and more effectively guide health care leaders on current strategic issues.
Health care disruptors forged ahead in 2020 despite the pandemic, but hospitals and health systems can embrace the opportunities for collaboration and partnership, writes Mital Patel, senior director of market intelligence at the AHA Center for Health Innovation.
In this AHA Physician Alliance podcast, Janine Adjo, M.D., chair and director of the pediatric residency program at SBH Health System Bronx, shares how she applied during COVID-19 skills learned from the Women’s Wellness through Equity and Leadership Project.
President Biden continued the national emergency for the COVID-19 pandemic beyond March 1.
The AHA and eight other hospital organizations urged Senate leaders to include additional COVID-19 relief funding for health care providers in the current reconciliation package.
The Department of Justice asked the U.S. Supreme Court to remand the appealed Arkansas and New Hampshire cases to the Department of Health and Human Services to determine the appropriate path forward for the demonstration projects.
The Food and Drug Administration's Office of Minority Health and Health Equity released two videos on COVID-19 vaccines and the importance of communities of color who have been disproportionately impacted by COVID-19 getting vaccinated to protect themselves and loved ones from the virus.
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines, and help train current and future health care personnel to prevent and control infectious disease.
President Biden will sign an executive order to create more resilient and secure supply chains for critical and essential goods, the White House announced, calling last year’s shortages of personal protective equipment for front-line health care workers “unacceptable.”
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective.